the antimicrobial activities of nalidixic acid-cephalexin ( ratio 1:1 ) and cinoxacin-cefadroxil ( ratio 1:2 ) combinations have been evaluated against 396 clinical isolates ;
C0007716
cephalexin
C0007538
cefadroxil